C.R.S.
Section 44-10-208
Feasibility report
- standing committee
- report
- definition
- repeal
(1)
Intentionally left blank —Ed.(a)
On or before July 1, 2024, the executive director shall submit to the general assembly a report analyzing the feasibility of establishing a standing committee to evaluate cannabinoids and cannabis-derived products for the purpose of determining and making recommendations regarding their safety profiles and potential for intoxication. The report must consider and recommend legislative action addressing the following subjects:(I)
The appropriate state agency or agencies to be involved in, and their role in, the evaluation process;(II)
The ability of a standing committee to determine safety profiles of cannabinoids and cannabis-derived products, including the process by which a standing committee would make such a determination;(III)
The ability of a standing committee to determine the potential for intoxication of cannabinoids and cannabis-derived products, including the process by which a standing committee would make such a determination;(IV)
Recommendations as to members of a standing committee and a process to make appointments of members to a standing committee;(V)
Recommendations regarding an operable timeline for implementation of a standing committee; and(VI)
The fiscal effects of and the resources needed to implement and administer a standing committee.(b)
To inform the feasibility report described in subsection (1)(a) of this section, the department may engage experts, including:(I)
The chief medical officer appointed pursuant to section 25-1-105 or the designee of the chief medical officer;(II)
The state toxicologist or the designee of the state toxicologist;(III)
An epidemiologist with expertise in designing and conducting observational studies or clinical trials;(IV)
A clinician familiar with dosage forms and routes of administration of relevant products;(V)
A medical toxicologist; and(VI)
A pharmacologist with expertise in drug development.(2)
As used in this section, “state toxicologist” means the director of the toxicology and environmental epidemiology office, or a successor office, in the department of public health and environment.(3)
This section is repealed, effective July 1, 2025.
Source:
Section 44-10-208 — Feasibility report - standing committee - report - definition - repeal, https://leg.colorado.gov/sites/default/files/images/olls/crs2023-title-44.pdf (accessed Oct. 20, 2023).
Up to date